Browse > Article

Radiolabeling of NOTA and DOTA with Positron Emitting $^{68}$Ga and Investigation of In Vitro Properties  

Jeong, Jae-Min (Department of Nuclear Medicine, Seoul National University College of Medicine)
Kim, Young-Ju (Department of Nuclear Medicine, Seoul National University College of Medicine)
Lee, Yun-Sang (Department of Nuclear Medicine, Seoul National University College of Medicine)
Lee, Dong-Soo (Department of Nuclear Medicine, Seoul National University College of Medicine)
Chung, June-Key (Department of Nuclear Medicine, Seoul National University College of Medicine)
Lee, Myung-Chul (Department of Nuclear Medicine, Seoul National University College of Medicine)
Publication Information
Nuclear Medicine and Molecular Imaging / v.43, no.4, 2009 , pp. 330-336 More about this Journal
Abstract
Purpose: We established radiolabeling conditions of NOTA and DOTA with a generator-produced PET radionuclide $^{68}$Ga and studied in vitro characteristics such as stability, serum protein binding, octanol/water distribution, and interference with other metal ions. Materials and Methods: Various concentrations of NOTA 3HCl and DOTA 4HCl were labeled with 1 mL $^{68}$GaCl$_3$ (0.18$\sim$5.75 mCi in 0.1 M HCl in various pH. NOTA 3HCl (0.373 mM) was labeled with $^{68}$GaCl$_3$(0.183$\sim$0.232 mCi/0.1 M HCl 1.0 mL) in the presence of CuCl$_2$, FeCl$_2$, InCl$_3$, FeCl$_3$, GaCl$_3$, MgCl$_2$ or CaCl$_2$ (0$\sim$6.07 mM) at room temperature. The labeling efficiencies of $^{68}$Ga-NOTA and $^{68}$Ga-DOTA were checked by ITLC-SG using acetone or saline as mobile phase. Stabilities, protein bindings, and octanol distribution coefficients of the labeled compounds also were investigated. Results: $^{68}$Ga-NOTA and $^{68}$Ga-DOTA were labeled optimally at pH 6.5 and pH 3.5, respectively, and the chelates were stable for 4 hr either in the reaction mixture at room temperature or in the human serum at 37$^{\circ}C$. NOTA was labeled at room temperature while DOTA required heating for labeling. $^{68}$Ga-NOTA labeling efficiency was reduced by CuCl$_2$, FeCl$_2$, InCl$_2$, FeCl$_3$ or CaCl$_3$, however, was not influenced by MgCl$_2$ or CaCl$_2$. The protein binding was low (2.04$\sim$3.32%). Log P value of $^{68}$Ga-NOTA was -3.07 indicating high hydrophilicity. Conclusion: We found that NOTA is a better bifunctional chelating agent than DOTA for $^{68}$Ga labeling. Although, $^{68}$Ga-NOTA labeling is interfered by various metal ions, it shows high stability and low serum protein binding.
Keywords
Ga-68; gallium; protein binding; bifunctional chelating agent; generator; NOTA; DOTA;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Ehrhardt GJ, Welch MJ. A new germanium-68/gallium-68 generator. J Nucl Med 1978;19:925-9   PUBMED
2 Jeong JM, Hong MK, Chang YS. Lee Y-S, Kim YJ, Cheon GJ, et al. Preparation of a promising angiogenesis PET imaging agent: $^{68}Ga$-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med 2008;49:830-6   DOI   ScienceOn
3 Breeman WA, Verbruggen AM. The $^{68}Get/^{68}Ga$ generator has high potential, but when can we use $^{68}Ga$-labelied tracers in clinical routine? Eur J Nucl Med Mol Imaging 2007;34:978-81   DOI   ScienceOn
4 Meyer G-J, Macke H, Schuhmacher J, Knapp WH, Hofmann M. $^{68}Ga$-Iabelled DOTA-derivatised pettide ligands. Eur J Nucl Med Mol Imaging 2004;31:1097-104   ScienceOn
5 Jeong JM, Hong MK, Kim YJ, Lee J, Kang JH, Lee DS, et al. Development of $^{99m}$Tc-neomannosyl human serum albumin ($^{99m}$Tc-MSA) as a novel receptor binding agent for sentinel lymph node imaging. Nucl Med Commun 2004;25:1211-7   DOI   ScienceOn
6 Zhernosekkov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash M et al. Processing of generator-produced $^{68}Ga$ for medical application. J Nucl Med 2007;48:1741-8   DOI   ScienceOn
7 Lee Y-S, Jeong JM, Kim HW, Chang YS, Kim YJ, Hong MK et al. An improved method of $^{99m}$F peptide labeling: hydrazone formation with HYNIC-conjugated c(RGDyK). Nucl Med Biol 2006;33:677-83   DOI   ScienceOn
8 Schuhmacher J, Maier-Borst W. A new $^{68}Get/^{68}Ga$ radioisotope generator system for production of $^{68}Ga$ in diliute HCl. Int J Appl Radiat Isot 1981;32:31-6
9 Jeong HJ. Review of radionuclide treatment for neuroendocrine tumors. Nucl Med Mol Imaging 2006;40:90-5   과학기술학회마을
10 Hoffend J, Mier W, Schuhmacher J, Schmidt K, Dimitrakopoulou-Strauss A, Strauss LG, et al. Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo. Nucl Med Biol 2005;32:287-92   DOI   ScienceOn
11 Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semi Nucl Med 2006;36:228-47   DOI   ScienceOn
12 Hsiao Y-U, Mathias CJ, Wey S-P, Fanwick PE, Green MA. Synthesis and biodistribution of lipophilic and monocationic gallium radiopharmaceuticals derived from N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine: potential agents for PET myocardial imaging with $^{68}Ga$. Nucl Med Biol 2009;36:39-45   DOI   ScienceOn
13 Lee J, Garmestani K, Wu C. Brechbiel MW, Chang HK, Choi CW, et al. In vitro and in vivo evaluation of structure-stability relationship of $^{111}$In- and $^{67}$Ga-labeled antibody via 1B4M or C-NOTA chelates. Nucl Med Biol 1997;24:225-30   DOI   ScienceOn
14 Parker D. Tumor targeting with radiolabeled macrocycle-antibody conjugates. Chem Soc Rev 1990;19:271-91   DOI
15 Chang YS, Jeong JM, Lee Y-S, Kim Hw, Rai GB, Lee SJ, et al. Preparation of $^{18}F$-Human Serum Albumin: A Simple and Efficient Protein Labeling Method with 18F Using a Hydrazone-Formation Method. Bioconjugate Chem 2005; 16:1329-33   DOI   ScienceOn